Home › NDC Lookup › RxCUI directory › RxCUI 244557

Benzocaine 0.2 MG/MG Topical Ointment — RxCUI 244557

RxNorm drug concept · Semantic clinical drug
RxCUI 244557 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI244557
Official nameBenzocaine 0.2 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzocaine 20 % Topical Ointment
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzocaine 0.2 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzocaine 0.2 MG/MG Topical Ointment RxCUI 244557

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Benzocaine 1399
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Americaine Hemorrhoidal 215204
    • BOIL-EASE 318132
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzocaine Topical Ointment 374423
    • Benzocaine Topical Product 1152975
    • Benzocaine Topical Ointment [Americaine Hemorrhoidal] 1426291
    • Benzocaine Topical Ointment [BOIL-EASE] 669213
    • Americaine Hemorrhoidal Topical Product 1426292
    • BOIL-EASE Topical Product 1167244
    • Topical Ointment 316985
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzocaine 0.2 MG/MG SCDC · 340000
  • Benzocaine Topical Ointment SCDF · 374423
  • Benzocaine Topical Product SCDG · 1152975

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 244557 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-9095-28 1 TUBE in 1 CARTON (0363-9095-28) / 28 g in 1 TUBE Walgreens Boil Pain Relief Walgreens Company 2024-02-01
59779-0444-28 1 BOX in 1 TUBE (59779-444-28) / 28 g in 1 BOX CVS Maximum Strength Boil Relief CVS Pharmacy, Inc. 2014-10-13
63736-0040-28 1 TUBE in 1 BOX (63736-040-28) / 28 g in 1 TUBE Boil Ease Insight Pharmaceuticals LLC 2010-06-21
63736-0375-01 1 TUBE in 1 BOX (63736-375-01) / 28 g in 1 TUBE Americaine Insight Pharmaceuticals LLC 2009-07-10
70372-0727-01 5 g in 1 POUCH (70372-727-01) BLT 1 CENTURA PHARMACEUTICALS INC 2016-10-15
Observed labelers: Insight Pharmaceuticals LLC (2) · CENTURA PHARMACEUTICALS INC (1) · CVS Pharmacy, Inc. (1) · Walgreens Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.